Bio Impact Capital LLC Verastem, Inc. Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$1.06 - $2.1 $28,494 - $56,452
-26,882 Reduced 0.82%
3,244,650 $4.58 Million
Q4 2021

Feb 11, 2022
BUY
$2.05 - $3.2 $915,683 - $1.43 Million
446,675 Added 15.81%
3,271,532 $6.71 Million
Q3 2021

Nov 15, 2021
BUY
$2.54 - $4.07 $7.18 Million - $11.5 Million
2,824,857 New
2,824,857 $8.7 Million

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.25B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email